Zevra Therapeutics Inc.

NASDAQ: ZVRA
Share price (1/6/25): $8.44
Market cap (1/6/25): $450 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus for primary offering

Shelf registration

Prospectus supplement

Ownership Filter

Nantahala Capital Management, LLC

Woodline Partners LP

Vanguard Group Inc

Vanguard Group Inc

Watton Corey Michael

News Filter

Announces Organizational Changes

Announces U.S. Commercial Availability of MIPLYFFA™ (Arimoclomol) for Treatment of Niemann-Pick Disease Type C

Reports Third Quarter 2024 Financial Results and Corporate Updates

Therapeutics’ MIPLYFFA™ (Arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C

Reports Second Quarter 2024 Financial Results and Corporate Highlights

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC